| Trial ID: | L1584 |
| Source ID: | NCT01101217
|
| Associated Drug: |
Zinc Supplement
|
| Title: |
Effect of Zinc Suplementation on Serum Hemosystein Level in Hemodialysis Patients
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
End Stage Renal Failure
|
| Interventions: |
DRUG: Zinc Supplement|DRUG: placebo
|
| Outcome Measures: |
Primary: decreased hemocystein level, 6 months |
|
| Sponsor/Collaborators: |
Sponsor: Shiraz University of Medical Sciences
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
100
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2009-02
|
| Completion Date: |
2009-09
|
| Results First Posted: |
|
| Last Update Posted: |
2010-04-09
|
| Locations: |
Shiraz University Hemodialysis Center, Shiraz,, Fars, 098, Iran, Islamic Republic of
|
| URL: |
https://clinicaltrials.gov/show/NCT01101217
|
